The impact of long-term targeted therapy with omalizumab (more than 2 years) on the asthma control according to the registry of children with uncontrolled severe persistent asthma (Russian experience)

被引：0
|
作者：
Namazova-Baranova, L. [1 ]
Vishneva, E. [1 ]
Dobrynina, E. [1 ]
Alekseeva, A. [1 ]
Levina, J. [1 ]
Efendieva, K. [1 ]
Kalugina, V [1 ]
Voznesenskaya, N. [1 ]
Selimzyanova, L. [1 ]
Promyslova, E. [1 ]
机构：
[1] Sci Ctr Childrens Hlth, Moscow, Russia
来源：
ALLERGY | 2017年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0976
引用
收藏
页码：559 / 560
页数：2
相关论文
共 50 条
  • [31] Omalizumab demonstrates long-term asthma control, safety and tolerability in patients with severe immunoglobulin E-mediated allergic asthma
    Chung, K.
    Holgate, S.
    Rolli, M.
    Gao, J.
    Reisner, C.
    ALLERGY, 2007, 62 : 210 - 210
  • [32] The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
    Tsyplenkova, Svetlana
    Mizernitskyi, Yuriy
    Sokolova, Ludmila
    Sorokina, Elena
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [33] LONG-TERM EFFECTIVENESS OF OMALIZUMAB IN PATIENTS WITH SEVERE PERSISTENT ALLERGIC (IGE-MEDIATED) ASTHMA: UK CENTRE REAL-LIFE EXPERIENCE
    Mansur, A. H.
    Mitchell, V.
    Alfridi, L.
    Sullivan, J.
    Kasujee, I.
    THORAX, 2013, 68 : A152 - A152
  • [34] Omalizumab, an anti-IgE monoclonal antibody, demonstrates long-term asthma control, safety and tolerability in patients with severe allergic asthma
    Hébert, J
    Rolli, M
    Gao, J
    Reisner, C
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S9 - S9
  • [35] The 'real-life' long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta
    Gouder, Caroline
    Asciak, Rachelle
    Montefort, Stephen
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [36] Correction: Corrigendum: Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis
    Tianwen Lai
    Shaobin Wang
    Zhiwei Xu
    Chao Zhang
    Yun Zhao
    Yue Hu
    Chao Cao
    Songmin Ying
    Zhihua Chen
    Wen Li
    Bin Wu
    Huahao Shen
    Scientific Reports, 5
  • [37] Short and long-term quality of life and asthma control with omalizumab therapy in a real life setting in Portugal
    Vieira, T.
    de Oliveira, J. F.
    da Graca Castel-Branco, M.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2014, 42 (01) : 3 - 10
  • [38] Long-term omalizumab treatment in severe allergic asthma: The South-Eastern Mediterranean "real-life" experience
    Tzortzaki, Eleni G.
    Georgiou, Andreas
    Kampas, Dimitrios
    Lemessios, Marinos
    Markatos, Miltiadis
    Adamidi, Tonia
    Samara, Katerina
    Skoula, Georgia
    Damianaki, Aggeliki
    Schiza, Sophia
    Tzanakis, Nikos
    Siafakas, Nikolaos M.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2012, 25 (01) : 77 - 82
  • [39] Evaluation of the long-term control of mild persistent asthma with montelukast or fluticasone in Slovene children aged 1-15 years
    Besednjak-Kocijancic, L.
    ALLERGY, 2008, 63 : 171 - 172
  • [40] Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
    Chen, Wenjia
    Tran, Trung N.
    Sadatsafavi, Mohsen
    Murray, Ruth
    Wong, Nigel Chong Boon
    Ali, Nasloon
    Ariti, Con
    Bulathsinhala, Lakmini
    Garcia, Esther
    FitzGerald, J. Mark
    Alacqua, Marianna
    Al-Ahmad, Mona
    Altraja, Alan
    Al-Lehebi, Riyad
    Bhutani, Mohit
    Bjermer, Leif
    Bjerrum, Anne-Sofie
    Bourdin, Arnaud
    von Bulow, Anna
    Busby, John
    Canonica, Giorgio Walter
    Carter, Victoria
    Christoff, George C.
    Cosio, Borja G.
    Costello, Richard W.
    Fonseca, Joao A.
    Gibson, Peter G.
    Yoo, Kwang-Ha
    Heaney, Liam G.
    Heffler, Enrico
    Hew, Mark
    Hilberg, Ole
    Hoyte, Flavia
    Iwanaga, Takashi
    Jackson, David J.
    Jones, Rupert C.
    Koh, Mariko Siyue
    Kuna, Piotr
    Larenas-Linnemann, Desiree
    Lehmann, Sverre
    Lehtimaki, Lauri
    Lyu, Juntao
    Mahboub, Bassam
    Maspero, Jorge
    Menzies-Gow, Andrew N.
    Newell, Anthony
    Sirena, Concetta
    Papadopoulos, Nikolaos G.
    Papaioannou, Andriana I.
    Perez-de-Llano, Luis
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (09): : 2732 - 2747
12345